Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Seek Labs a biotech company boldly seeking a healthier world through AIpowered discovery programmable therapeutics and pointofcare diagnostics today announced successful mapping of the Respiratory Syncytial Virus
JCR Pharmaceuticals Co Ltdtoday announced that it has entered into a license agreement with Alexion AstraZeneca Rare Disease Alexion for JCRs new proprietary JUSTAAV capsids to develop genomic medicines
Adagene Inc a company transforming the discovery and development of novel antibodybased therapies today announced a partnership with ConjugateBio Inc ConjugateBio to provide a proprietary antibody for use in partner companies
CStone Pharmaceuticalsan innovationdriven biopharmaceutical company focused on oncology today announced an exclusive partnership with Istituto Gentili Gentili a leading European biopharmaceutical company
NYBAI and Pnaseer Inc Pnaseer have announced a strategic partnership to accelerate the discovery of compounds that promote hair follicle regeneration using artificial intelligence AI
Celltrion USA today announced that STOBOCLO denosumabbmwo and OSENVELT denosumabbmwo biosimilars referencing PROLIA denosumab and XGEVA denosumab respectively are commercially available in the United States
ImmunityBio Inctoday announced that the UK Medicines and Healthcare products Regulatory Agency MHRA has granted marketing authorization for ANKTIVA nogapendekin alfa inbakiceptpmln in combination with Bacillus CalmetteGurin BCG for the treatment of c...
SCG Cell Therapy Pte Ltd SCG a clinicalstage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers announced today that the China National Medical Products Administration NMPA has cleared the Investigation...
Global pharma major Lupin Limited Lupin today announced the launch of Ipratropium Bromide Nasal Solution Nasal Spray and in the United States Ipratropium Bromide Nasal Solution Nasal Spray
AstraZenecas Imfinzi durvalumab has been approved in the European Union EU for the treatment of adult patients with resectable muscleinvasive bladder cancer MIBC in combination with gemcitabine and cisplatin as neoadjuvant treatment
